{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:35:45Z","timestamp":1794357345184,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":72,"publisher":"Humana Press","isbn-type":[{"value":"9781588298973","type":"print"},{"value":"9781597452342","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008]]},"DOI":"10.1007\/978-1-59745-234-2_14","type":"book-chapter","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T15:26:16Z","timestamp":1216913176000},"page":"197-227","source":"Crossref","is-referenced-by-count":39,"title":["Molecular Diagnosis of Human Prion Disease"],"prefix":"10.1007","author":[{"given":"Jonathan D. F.","family":"Wadsworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Joiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"14_CR1_14","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB. Prusiner","year":"1998","unstructured":"Prusiner SB. (1998) Prions. Proc Natl Acad Sci U S A;95:13363\u201313383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR2_14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J. Collinge","year":"2001","unstructured":"Collinge J. (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci;24:519\u2013550.","journal-title":"Annu Rev Neurosci"},{"key":"14_CR3_14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/jnnp.2004.048660","volume":"76","author":"J. Collinge","year":"2005","unstructured":"Collinge J. (2005) Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry; 76:906\u2013919.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR4_14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/bmb\/66.1.241","volume":"66","author":"JD Wadsworth","year":"2003","unstructured":"Wadsworth JD, Hill AF, Beck JA, Collinge J. (2003) Molecular and clinical classification of human prion disease. Br Med Bull;66:241\u2013254.","journal-title":"Br Med Bull"},{"key":"14_CR5_14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbadis.2007.02.010","volume":"1772","author":"JD Wadsworth","year":"2007","unstructured":"Wadsworth JD, Collinge J. (2007) Update on human prion disease. Biochim Biophys Acta; 1772:598\u2013609.","journal-title":"Biochim Biophys Acta"},{"key":"14_CR6_14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrmicro1025","volume":"2","author":"C. Weissmann","year":"2004","unstructured":"Weissmann C. (2004) The state of the prion. Nat Rev Microbiol;2:861\u2013871.","journal-title":"Nat Rev Microbiol"},{"key":"14_CR7_14","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1126\/science.274.5295.2079","volume":"274","author":"GC Telling","year":"1996","unstructured":"Telling GC, Parchi P, DeArmond SJ, et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science;274:2079\u20132082.","journal-title":"Science"},{"key":"14_CR8_14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/383685a0","volume":"383","author":"J Collinge","year":"1996","unstructured":"Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. (1996) Molecular analysis of prion strain variation and the aetiology of \u2018new variant\u2019 CJD. Nature;383:685\u2013690.","journal-title":"Nature"},{"key":"14_CR9_14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ana.410390613","volume":"39","author":"P Parchi","year":"1996","unstructured":"Parchi P, Castellani R, Capellari S, et al. (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol;39:767\u2013778.","journal-title":"Ann Neurol"},{"key":"14_CR10_14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/9030","volume":"1","author":"JDF Wadsworth","year":"1999","unstructured":"Wadsworth JDF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J. (1999) Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol;1:55\u201359.","journal-title":"Nat Cell Biol"},{"key":"14_CR11_14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, et al. (1999) Classification of sporadic Creutzfeldt-Jakob Disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol; 46:224\u2013233.","journal-title":"Ann Neurol"},{"key":"14_CR12_14","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/brain\/awg125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill AF, Joiner S, Wadsworth JD, et al. (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain;126:1333\u20131346.","journal-title":"Brain"},{"key":"14_CR13_14","doi-asserted-by":"publisher","first-page":"38936","DOI":"10.1074\/jbc.M405468200","volume":"79","author":"G Zanusso","year":"2004","unstructured":"Zanusso G, Farinazzo A, Prelli F, et al. (2004) Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J Biol Chem;79: 38936\u201338942.","journal-title":"J Biol Chem"},{"key":"14_CR14_14","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1073\/pnas.0409651102","volume":"102","author":"JG Safar","year":"2005","unstructured":"Safar JG, Geschwind MD, Deering C, et al. (2005) Diagnosis of human prion disease. Proc Natl Acad Sci U S A;102:3501\u20133506.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR15_14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/brain\/awl013","volume":"129","author":"A Hill","year":"2006","unstructured":"Hill A, Joiner S, Beck J, et al. (2006) Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain;129:676\u2013685.","journal-title":"Brain"},{"key":"14_CR16_14","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.1073\/pnas.101130398","volume":"98","author":"SE Lloyd","year":"2001","unstructured":"Lloyd SE, Onwuazor ON, Beck JA, et al. (2001) Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A;98:6279\u20136283.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR17_14","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1093\/emboj\/cdf653","volume":"21","author":"EA Asante","year":"2002","unstructured":"Asante EA, Linehan JM, Desbruslais M, et al. (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J;21:6358\u20136366.","journal-title":"EMBO J"},{"key":"14_CR18_14","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/hmg\/6.10.1699","volume":"6","author":"J. Collinge","year":"1997","unstructured":"Collinge J. (1997) Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genetics;6:1699\u20131705.","journal-title":"Hum Mol Genetics"},{"key":"14_CR19_14","volume-title":"Prion Diseases.","author":"J Collinge","year":"1997","unstructured":"Collinge J, Palmer.M.S. (1997) Prion Diseases. 1st ed. Oxford: Oxford University Press.","edition":"1st ed."},{"key":"14_CR20_14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1212\/WNL.37.6.895","volume":"37","author":"P Brown","year":"1987","unstructured":"Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. (1987) The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology;37:895\u2013904.","journal-title":"Neurology"},{"key":"14_CR21_14","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/brain\/awl159","volume":"129","author":"SJ Collins","year":"2006","unstructured":"Collins SJ, Sanchez-Juan P, Masters CL, et al. (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain;129:2278\u20132287.","journal-title":"Brain"},{"key":"14_CR22_14","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-002-0896-9","volume":"249","author":"GG Kovacs","year":"2002","unstructured":"Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol; 249:1567\u20131582.","journal-title":"J Neurol"},{"key":"14_CR23_14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.ejhg.5201544","volume":"14","author":"S. Mead","year":"2006","unstructured":"Mead S. (2006) Prion disease genetics. Eur J Hum Genet;14:273\u2013281.","journal-title":"Eur J Hum Genet"},{"key":"14_CR24_14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0140-6736(92)92431-E","volume":"340","author":"P Brown","year":"1992","unstructured":"Brown P, Preece MA, Will RG. (1992) \u201cFriendly fire\u201d in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet;340:24\u201327.","journal-title":"Lancet"},{"key":"14_CR25_14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","volume":"55","author":"P Brown","year":"2000","unstructured":"Brown P, Preece M, Brandel JP, et al. (2000) Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology;55:1075\u20131081.","journal-title":"Neurology"},{"key":"14_CR26_14","first-page":"451","volume-title":"Prions: Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease.","author":"MP. Alpers","year":"1987","unstructured":"Alpers MP. Epidemiology and clinical aspects of kuru. (1987) In: Prusiner SB, McKinley MP, editors. Prions: Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease. San Diego: Academic Press, 451\u2013465."},{"key":"14_CR27_14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.1083320","volume":"300","author":"S Mead","year":"2003","unstructured":"Mead S, Stumpf MP, Whitfield J, et al. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science;300:640\u2013643.","journal-title":"Science"},{"key":"14_CR28_14","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","volume":"367","author":"J Collinge","year":"2006","unstructured":"Collinge J, Whitfield J, McKintosh E, et al. (2006) Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet;367:2068\u20132074.","journal-title":"Lancet"},{"key":"14_CR29_14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","volume":"347","author":"RG Will","year":"1996","unstructured":"Will RG, Ironside JW, Zeidler M, et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet;347:921\u2013925.","journal-title":"Lancet"},{"key":"14_CR30_14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/38925","volume":"389","author":"AF Hill","year":"1997","unstructured":"Hill AF, Desbruslais M, Joiner S, et al. (1997) The same prion strain causes vCJD and BSE. Nature;389:448\u2013450.","journal-title":"Nature"},{"key":"14_CR31_14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/39057","volume":"389","author":"ME Bruce","year":"1997","unstructured":"Bruce ME, Will RG, Ironside JW, et al. (1997) Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent. Nature;389:498\u2013501.","journal-title":"Nature"},{"key":"14_CR32_14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0140-6736(99)05128-4","volume":"354","author":"J. Collinge","year":"1999","unstructured":"Collinge J. (1999) Variant Creutzfeldt-Jakob disease. Lancet;354:317\u2013323.","journal-title":"Lancet"},{"key":"14_CR33_14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/path.1580","volume":"203","author":"DA Hilton","year":"2004","unstructured":"Hilton DA, Ghani AC, Conyers L, et al. (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol;203:733\u2013739.","journal-title":"J Pathol"},{"key":"14_CR34_14","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(04)17143-2","volume":"364","author":"A Frosh","year":"2004","unstructured":"Frosh A, Smith LC, Jackson CJ, et al. (2004) Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet;364:1260\u20131262.","journal-title":"Lancet"},{"key":"14_CR35_14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/path.1880","volume":"208","author":"DA. Hilton","year":"2005","unstructured":"Hilton DA. (2005) Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J Pathol;208:134\u2013141.","journal-title":"J Pathol"},{"key":"14_CR36_14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","volume":"358","author":"JDF Wadsworth","year":"2001","unstructured":"Wadsworth JDF, Joiner S, Hill AF, et al. (2001) Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay. Lancet;358:171\u2013180.","journal-title":"Lancet"},{"key":"14_CR37_14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","volume":"363","author":"CA Llewelyn","year":"2004","unstructured":"Llewelyn CA, Hewitt PE, Knight RS, et al. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet;363:417\u2013421.","journal-title":"Lancet"},{"key":"14_CR38_14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","volume":"364","author":"AH Peden","year":"2004","unstructured":"Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet; 364:527\u2013529.","journal-title":"Lancet"},{"key":"14_CR39_14","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","volume":"368","author":"SJ Wroe","year":"2006","unstructured":"Wroe SJ, Pal S, Siddique D, et al. (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet;368:2061\u20132067.","journal-title":"Lancet"},{"key":"14_CR40_14","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/0140-6736(91)93128-V","volume":"337","author":"J Collinge","year":"1991","unstructured":"Collinge J, Palmer MS, Dryden AJ. (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet;337:1441\u20131442.","journal-title":"Lancet"},{"key":"14_CR41_14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/352340a0","volume":"352","author":"MS Palmer","year":"1991","unstructured":"Palmer MS, Dryden AJ, Hughes JT, Collinge J. (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature; 352:340\u2013342.","journal-title":"Nature"},{"key":"14_CR42_14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s004390050204","volume":"98","author":"O Windl","year":"1996","unstructured":"Windl O, Dempster M, Estibeiro JP, et al. (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet;98:259\u2013264.","journal-title":"Hum Genet"},{"key":"14_CR43_14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1086\/317935","volume":"183","author":"HS Lee","year":"2001","unstructured":"Lee HS, Brown P, Cerven\u00e1kov\u00e1 L, et al. (2001) Increased susceptibility to Kuru of carriers of the PRNP 129 methionine\/methionine genotype. J Infect Dis;183:192\u2013196.","journal-title":"J Infect Dis"},{"key":"14_CR44_14","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1126\/science.1103932","volume":"306","author":"JD Wadsworth","year":"2004","unstructured":"Wadsworth JD, Asante EA, Desbruslais M, et al. (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science;306:1793\u20131796.","journal-title":"Science"},{"key":"14_CR45_14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0140-6736(89)90256-0","volume":"2","author":"J Collinge","year":"1989","unstructured":"Collinge J, Harding AE, Owen F, et al. (1989) Diagnosis of Gerstmann-Str\u00e4ussler syndrome in familial dementia with prion protein gene analysis. Lancet;2:15\u201317.","journal-title":"Lancet"},{"key":"14_CR46_14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0140-6736(90)91518-F","volume":"336","author":"J Collinge","year":"1990","unstructured":"Collinge J, Owen F, Poulter M, et al. (1990) Prion dementia without characteristic pathology. Lancet;336:7\u20139.","journal-title":"Lancet"},{"key":"14_CR47_14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/brain\/115.3.687","volume":"115","author":"J Collinge","year":"1992","unstructured":"Collinge J, Brown J, Hardy J, et al. (1992) Inherited prion disease with 144 base pair gene insertion: II: clinical and pathological features. Brain;115:687\u2013710.","journal-title":"Brain"},{"key":"14_CR48_14","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/brain\/122.10.1823","volume":"122","author":"GR Mallucci","year":"1999","unstructured":"Mallucci GR, Campbell TA, Dickinson A, et al.(1999) Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain;122:1823\u20131837.","journal-title":"Brain"},{"key":"14_CR49_14","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/brain\/awl226","volume":"129","author":"S Mead","year":"2006","unstructured":"Mead S, Poulter M, Beck J, et al. (2006) Inherited prion disease with six octapeptide repeat insertional mutation\u2014molecular analysis of phenotypic heterogeneity. Brain; 129:2297\u20132317.","journal-title":"Brain"},{"key":"14_CR50_14","unstructured":"World Health Organisation. (2003) WHO manual for surveillance of human transmissible spongiform encephalopathies. \n                  http:\/\/www.who.int\/bloodproducts\/TSE-manual2003.pdf"},{"key":"14_CR51_14","first-page":"1351","volume":"49","author":"J Collinge","year":"1991","unstructured":"Collinge J, Poulter M, Davis MB, et al. (1991) Presymptomatic detection or exclusion of prion protein gene defects in families with inherited prion diseases. Am J Hum Genet;49:1351\u20131354.","journal-title":"Am J Hum Genet"},{"key":"14_CR52_14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","volume":"5","author":"H Budka","year":"1995","unstructured":"Budka H, Aguzzi A, Brown P, et al. (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol;5:459\u2013466.","journal-title":"Brain Pathol"},{"key":"14_CR53_14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/bmb\/66.1.121","volume":"66","author":"H. Budka","year":"2003","unstructured":"Budka H. Neuropathology of prion diseases. (2003) Br Med Bull;66:121\u2013130.","journal-title":"Br Med Bull"},{"key":"14_CR54_14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1750-3639.1995.tb00596.x","volume":"5","author":"JA Hainfellner","year":"1995","unstructured":"Hainfellner JA, Brantner-Inthaler S, Cerven\u00e1kov\u00e1 L, et al. (1995) The original Gerstmann-Str\u00e4ussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol;5:201\u2013211.","journal-title":"Brain Pathol"},{"key":"14_CR55_14","first-page":"133","volume":"284","author":"JW Ironside","year":"2004","unstructured":"Ironside JW, Head MW. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. (2004) Curr Top Microbiol Immunol;284:133\u2013159.","journal-title":"Curr Top Microbiol Immunol"},{"key":"14_CR56_14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(98)12075-5","volume":"353","author":"AF Hill","year":"1999","unstructured":"Hill AF, Butterworth RJ, Joiner S, et al. (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet;353:183\u2013189.","journal-title":"Lancet"},{"key":"14_CR57_14","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa030351","volume":"349","author":"M Glatzel","year":"2003","unstructured":"Glatzel M, Abela E, Maissen M, Aguzzi A. (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med;349:1812\u20131820.","journal-title":"N Engl J Med"},{"key":"14_CR58_14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/jcp.2003.012278","volume":"57","author":"DA Hilton","year":"2004","unstructured":"Hilton DA, Sutak J, Smith ME, et al. (2004) Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol;57:300\u2013302.","journal-title":"J Clin Pathol"},{"key":"14_CR59_14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0002-9440(10)63105-7","volume":"164","author":"MW Head","year":"2004","unstructured":"Head MW, Ritchie D, Smith N, et al. (2004) Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol;164:143\u2013153.","journal-title":"Am J Pathol"},{"key":"14_CR60_14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/gut.2005.072447","volume":"54","author":"S Joiner","year":"2005","unstructured":"Joiner S, Linehan JM, Brandner S, Wadsworth JD, Collinge J. (2005) High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease. Gut;54:1506\u20131508.","journal-title":"Gut"},{"key":"14_CR61_14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gut.2006.091637","volume":"56","author":"JD Wadsworth","year":"2007","unstructured":"Wadsworth JD, Joiner S, Fox K, et al. (2007) Prion infectivity in vCJD rectum. Gut;56:90\u201394.","journal-title":"Gut"},{"key":"14_CR62_14","first-page":"S1","volume":"238","author":"D Siddique","year":"2005","unstructured":"Siddique D, Kennedy A, Thomas D, et al. (2005) Tonsil biopsy in the investigation of suspected variant Creutzfeldt-Jakob disease\u2014a cohort study of 50 patients. J Neurol Sci;238:S1\u2013S570.","journal-title":"J Neurol Sci"},{"key":"14_CR63_14","unstructured":"Advisory Committee on Dangerous Pathogens and the Spongiform Encephalopathy Advisory Committee. (2003) Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. UK Department of Health. \n                  http:\/\/www.advisorybodies.doh.gov.uk\/ acdp\/tseguidance\/Index.htm"},{"key":"14_CR64_14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/2654","volume":"4","author":"J Safar","year":"1998","unstructured":"Safar J, Wille H, Itri V, et al. (1998) Eight prion strains have PrPSc molecules with different conformations. Nat Med; 4:1157\u20131165.","journal-title":"Nat Med"},{"key":"14_CR65_14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/bmb\/66.1.21","volume":"66","author":"D. Riesner","year":"2003","unstructured":"Riesner D. (2003) Biochemistry and structure of PrPC and PrPSc. Br Med Bull;66:21\u201333.","journal-title":"Br Med Bull"},{"key":"14_CR66_14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/386232a0","volume":"386","author":"P Parchi","year":"1997","unstructured":"Parchi P, Capellari S, Chen SG, et al. (1997) Typing prion isoforms. Nature;386:232\u2013233.","journal-title":"Nature"},{"key":"14_CR67_14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/00005072-199810000-00010","volume":"57","author":"P Piccardo","year":"1998","unstructured":"Piccardo P, Dlouhy SR, Lievens PMJ, et al. (1998) Phenotypic variability of Gerstmann-Str\u00e4ussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol;57:979\u2013988.","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR68_14","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.1073\/pnas.95.14.8322","volume":"95","author":"P Parchi","year":"1998","unstructured":"Parchi P, Chen SG, Brown P, et al. (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Str\u00e4ussler-Scheinker disease. Proc Natl Acad Sci U S A;95:8322\u20138327.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR69_14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0022-510X(98)00096-3","volume":"158","author":"H Furukawa","year":"1998","unstructured":"Furukawa H, Doh-ura K, Kikuchi H, Tateishi J, Iwaki T. (1998) A comparative study of abnormal prion protein isoforms between Gerstmann-Str\u00e4ussler-Scheinker syndrome and Creutzfeldt-Jakob disease. J Neurol Sci;158:71\u201375.","journal-title":"J Neurol Sci"},{"key":"14_CR70_14","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0002-9440(10)64692-5","volume":"158","author":"P Piccardo","year":"2001","unstructured":"Piccardo P, Liepnieks JJ, William A, et al. (2001) Prion proteins with different conformations accumulate in Geustmann-Str\u00e4ussler-Scheinker disease caused by A117V and F198S mutations. Am J Pathol;158:2201\u20132207.","journal-title":"Am J Pathol"},{"key":"14_CR71_14","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1074\/jbc.M007062200","volume":"276","author":"F Tagliavini","year":"2001","unstructured":"Tagliavini F, Lievens PMJ, Tranchant C, et al. (2001) A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Str\u00e4ussler-Scheinker disease A117V. J Biol Chem;276:6009\u20136015.","journal-title":"J Biol Chem"},{"key":"14_CR72_14","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/brain\/awl076","volume":"129","author":"JD Wadsworth","year":"2006","unstructured":"Wadsworth JD, Joiner S, Linehan JM, et al. (2006) Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain;129:1557\u20131569.","journal-title":"Brain"}],"container-title":["Methods in Molecular Biology","Prion Protein Protocols"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-59745-234-2_14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T17:39:06Z","timestamp":1619890746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-59745-234-2_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"ISBN":["9781588298973","9781597452342"],"references-count":72,"URL":"https:\/\/doi.org\/10.1007\/978-1-59745-234-2_14","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-59745-234-2","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}